Bioink: a 3D-bioprinting tool for anticancer drug discovery and cancer management

Arpita P Tiwari,Nanasaheb D Thorat,Sabrina Pricl,Rakesh M Patil,Sonali Rohiwal,Helen Townley
DOI: https://doi.org/10.1016/j.drudis.2021.03.010
Abstract:'Bioinks' are important tools for the fabrication of artificial living-tissue constructs that are able to mimic all properties of native tissues via 3D bioprinting technologies. Bioinks are most commonly made by incorporating live cells of interest within a natural or synthetic biocompatible polymeric matrix. In oncology research, the ability to recreate a tumor microenvironment (TME) using by 3D bioprinting constitutes a promising approach for drug development, screening, and in vitro cancer modeling. Here, we review the different types of bioink used for 3D bioprinting, with a focus on its application in cancer management. In addition, we consider the fabrication of bioink using customized materials/cells and their properties in the field of cancer drug discovery.
What problem does this paper attempt to address?